Moderna stock fell 2.32% on April 3 due to concerns over a patent infringement complaint from Arbutus Biopharma. Despite challenges in 2023, Moderna anticipates reasonable revenue in 2024, with a ...
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
Moderna claims it is due compensation for products manufactured after March 7 last year. But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid". The hearing ...
Kenya's tourism minister, clarified that while the agreement is not entirely terminated, it has been put on hold for evaluation. Moderna has stalled on purchasing land in the Tatu City economic ...
Shares of Moderna (MRNA) are moving up on Tuesday afternoon after the company released positive data for its individualized cancer vaccine tested in combination with Merck's Keytruda (MRK).
A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
, opens new tab said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
World Health Organization’s top scientist said this week the recent bird flu outbreak is of “great concern” to public health, and vaccine development to halt the virus is “not where we ...